These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 36463771)

  • 1. Psychotropics and COVID-19: An analysis of safety and prophylaxis.
    Javelot H; Straczek C; Meyer G; Gitahy Falcao Faria C; Weiner L; Drapier D; Fakra E; Fossati P; Weibel S; Dizet S; Langrée B; Masson M; Gaillard R; Leboyer M; Llorca PM; Hingray C; Haffen E; Yrondi A
    Encephale; 2021 Dec; 47(6):564-588. PubMed ID: 34548153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol Consumption is Associated with Poor Prognosis in Obese Patients with COVID-19: a Mendelian Randomization Study using UK Biobank.
    Fan X; Liu Z; Poulsen KL; Wu X; Miyata T; Dasarathy S; Rotroff DM; Nagy LE
    medRxiv; 2020 Nov; ():. PubMed ID: 33269370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Habitual fish oil use and risk of COVID-19-related outcomes: Evidence from a large scale cohort study and Mendelian randomization analysis.
    Ma Y; Zhang L; Zeng R; Jiang R; Luo D; Wu H; Zhuo Z; Yang Q; Li J; Leung FW; Duan C; Sha W; Chen H
    Clin Nutr; 2023 Aug; 42(8):1399-1407. PubMed ID: 37429103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey.
    Mueller JK; Ahrens KF; Bauer M; Baune BT; Borgwardt S; Deckert J; Domschke K; Ellwanger R; Fallgatter A; Frodl T; Gallinat J; Gottschalk R; Grabe HJ; Hasan A; Herpertz SC; Hurlemann R; Jessen F; Kambeitz J; Kircher T; Kornhuber J; Lieb K; Meyer-Lindenberg A; Rupprecht R; Scherbaum N; Schlang C; Schneider A; Schomerus G; Thoma A; Unterecker S; Walter M; Walter H; Reif A; Reif-Leonhard C
    Pharmacopsychiatry; 2023 Nov; 56(6):227-238. PubMed ID: 37944561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK biobank: Enhanced assessment of the epidemiology and long-term impact of coronavirus disease-2019.
    Feng Q; Lacey B; Bešević J; Omiyale W; Conroy M; Starkey F; Calvin C; Callen H; Bramley L; Welsh S; Young A; Effingham M; Young A; Collins R; Holliday J; Allen N
    Camb Prism Precis Med; 2023; 1():e30. PubMed ID: 38550926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning identified genetic variants for COVID-19-related mortality among 28,097 affected cases in UK Biobank.
    Liu Z; Dai W; Wang S; Yao Y; Zhang H
    Genet Epidemiol; 2023 Apr; 47(3):215-230. PubMed ID: 36691909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic drugs use during the COVID-19 pandemic among Lebanese patients using psychotropics: An opportunity for generic drug promotion.
    Hatem G; Ankouni A; Salhab S; Kteich W; Awada S
    J Generic Med; 2023 Jun; 19(2):92-100. PubMed ID: 38603350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postacute Sequelae of SARS-CoV-2 Infection.
    Batra A; Nath A; Koralnik IJ
    JAMA; 2023 Oct; 330(15):1491-1492. PubMed ID: 37847279
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and pharmacological implications for a high rate of unrecognized SARS-CoV-2 infected psychiatric patients.
    Vai B; Mazza MG
    Brain Behav Immun; 2024 Feb; 116():124-125. PubMed ID: 38070617
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of deaths from coronavirus COVID-19: A challenge for clinical medicine?
    Medina Gamero AR; Regalado Chamorro ME
    Med Clin (Barc); 2021 Dec; 157(11):e345. PubMed ID: 34059355
    [No Abstract]   [Full Text] [Related]  

  • 11. The peculiarities of COVID-19 in older people: Considerations after two years.
    Trevisan C; Okoye C; Antonelli Incalzi R;
    Eur J Intern Med; 2023 Nov; 117():45-49. PubMed ID: 37778903
    [No Abstract]   [Full Text] [Related]  

  • 12. Measuring serum concentrations of psychotropics- Valuable tool for decision making or waste of money?
    Grunze H
    Eur Neuropsychopharmacol; 2023 Nov; 76():20-22. PubMed ID: 37480675
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 and cognition: what is next for our older population?
    Hack E; Kane R
    Intern Med J; 2024 Apr; 54(4):693-694. PubMed ID: 38637285
    [No Abstract]   [Full Text] [Related]  

  • 14. Better recognition for research participants: what society should learn from covid-19.
    Kraft SA; Rohrig A; Williams A; Shah SK
    BMJ; 2023 Jan; 380():e071178. PubMed ID: 36649969
    [No Abstract]   [Full Text] [Related]  

  • 15. Navigating the Novel Psychotropics.
    Dunlop BW
    Focus (Am Psychiatr Publ); 2021 Jan; 19(1):1-2. PubMed ID: 34483760
    [No Abstract]   [Full Text] [Related]  

  • 16. Antidepressant drug prescription and incidence of COVID-19 in mental health outpatients: a retrospective cohort study.
    Glebov OO; Mueller C; Stewart R; Aarsland D; Perera G
    BMC Med; 2023 Jun; 21(1):209. PubMed ID: 37340474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of psychotropics on the risk of COVID-19 in middle-aged and older adults.
    Ma Y; Li S; Yang H; Zhang Y; Li H; Xu F; Hou Y; Zhang X; Wang Y
    Eur Neuropsychopharmacol; 2023 Jan; 66():67-77. PubMed ID: 36463771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
    Javelot H; Llorca PM; Drapier D; Fakra E; Hingray C; Meyer G; Dizet S; Egron A; Straczek C; Roser M; Masson M; Gaillard R; Fossati P; Haffen E
    Encephale; 2020 Jun; 46(3S):S14-S34. PubMed ID: 32376004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate Psychotropics against SARS - CoV - 2: A Narrative Review.
    Khosravi M
    Pharmacopsychiatry; 2022 Jan; 55(1):16-23. PubMed ID: 34399430
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.